Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release systems are modified-release formulations that postpone drug release until the medication reaches a specific site in the gastrointestinal tract, typically the intestine. They address challenges like gastric irritation and acid-induced drug degradation while enabling localized therapeutic action. These systems are particularly valuable for drugs that cause stomach damage or are unstable in acidic environments.

Enteric coatings use pH-sensitive polymers like cellulose acetate phthalate or methacrylic acid copolymers to prevent drug dissolution in the stomach's low pH (1–3) and enable release in the higher intestinal pH (5–7.5). The drug remains intact while passing through the stomach and begins dissolving only upon reaching the intestine, minimizing gastric side effects and enhancing therapeutic efficacy.

Enteric-coated aspirin and diclofenac are common examples of delayed-release formulations used to reduce gastrointestinal irritation caused by nonsteroidal anti-inflammatory drugs. Mesalamine represents a specialized targeted-release system designed to release medication in the terminal ileum and colon for treating inflammatory bowel diseases like ulcerative colitis and Crohn's disease.

Delayed-release systems postpone drug release until reaching the intestine using pH-sensitive coatings, while targeted-release systems like mesalamine employ additional mechanisms such as time-dependent release or biodegradable polymers activated by colonic bacteria to achieve precise drug localization at specific intestinal sites for enhanced therapeutic outcomes.

Nonsteroidal anti-inflammatory drugs like aspirin and diclofenac can cause gastric mucosal damage when released in the stomach. Delayed-release formulations reduce gastrointestinal irritation by delaying drug release until the medication reaches the intestine, protecting the stomach lining while maintaining therapeutic efficacy and minimizing systemic side effects.

Enteric coatings typically employ pH-sensitive polymers such as cellulose acetate phthalate and methacrylic acid copolymers. These materials provide site-specific protection by resisting dissolution in the acidic gastric environment and dissolving at higher intestinal pH levels, ensuring controlled drug release at the target site.

Colonic delivery systems use biodegradable polymers activated by colonic bacteria to achieve precise drug localization in the colon. These formulations may combine time-dependent mechanisms with pH-sensitive coatings to ensure the drug reaches the target site intact, enabling effective treatment of colonic diseases while minimizing exposure to upper gastrointestinal tissues.